STOCK TITAN

Cassava Sciences to Hold Corporate Update on November 25th

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Cassava Sciences (NASDAQ: SAVA) announced it will host a corporate update via conference call and webcast on Monday, November 25th at 8:00 AM ET. The biotechnology company, which focuses on developing novel Alzheimer's disease treatments, will make the webcast available through their website, with a replay accessible for 90 days following the event on the Company Presentations page.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-83.78% News Effect

On the day this news was published, SAVA declined 83.78%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Webcast planned for Monday, November 25th at 8:00 AM ET

AUSTIN, Texas, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for Alzheimer’s disease, today announced it will hold a conference call and webcast on Monday, November 25th at 8:00 a.m. Eastern Time.

  
Event Details:
  
Date: Monday, November 25th
Time: 8:00 a.m. Eastern Time
Webcast: https://lifescievents.com/event/cassava/
  

A replay of the audio webcast will also be available on the Company Presentations page of the Cassava Sciences website for 90 days following the webcast.

About Cassava Sciences, Inc.

Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease.

Simufilam is an investigational oral, small molecule drug candidate currently being evaluated in two Phase 3 clinical trials for the potential treatment of Alzheimer's disease. Simufilam is a proprietary, investigational oral small molecule that targets the filamin A protein. Cassava Sciences owns exclusive, worldwide rights to its investigational product candidates and related technologies, without royalty obligations to any third party.

For more information, please visit: https://www.CassavaSciences.com

For More Information Contact:
Investors

Sandya von der Weid
svonderweid@lifesciadvisors.com

Media
media@cassavasciences.com

Company
Eric Schoen, Chief Financial Officer
(512) 501-2450
ESchoen@CassavaSciences.com 
ir@cassavasciences.com


FAQ

When is Cassava Sciences (SAVA) holding its corporate update webcast?

Cassava Sciences (SAVA) is holding its corporate update webcast on Monday, November 25th at 8:00 AM Eastern Time.

How long will the replay of SAVA's November 25th webcast be available?

The replay of Cassava Sciences' webcast will be available for 90 days following the event on the Company Presentations page of their website.

Where can I access Cassava Sciences' (SAVA) November 25th corporate update webcast?

The webcast can be accessed at https://lifescievents.com/event/cassava/ and will also be available on Cassava Sciences' website.
Cassava Sciences

NASDAQ:SAVA

SAVA Rankings

SAVA Latest News

SAVA Latest SEC Filings

SAVA Stock Data

137.68M
42.11M
12.79%
25.22%
12.69%
Biotechnology
Pharmaceutical Preparations
Link
United States
AUSTIN